Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Axogen, Inc. (AXGN)
Sector: Healthcare; Industry: Medical Devices

AxoGen, Inc., together with its subsidiaries, provides surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. AxoGen, Inc. is headquartered in Alachua, Florida.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-12-29 MARIANI PETER J Chief Financial Officer Sell 1,293 $17.81 $23,028 No
2020-12-21 MARIANI PETER J Chief Financial Officer Sell 481 $16.42 $7,898 No
2020-10-30 MARIANI PETER J Chief Financial Officer Sell 75,683 $12.41 $939,353 Yes
2016-10-07 MARIANI PETER J Chief Financial Officer Buy 3,333 $7.50 $24,998 No

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.